Document RajNOBg0GqaGNdVmbYkDmLqX8
bcc: F. W. Steinberg
INDUSTRIES
PPG INDUSTRIES, INC./ONE GATEWAY CENTER/PITTSBURGH, PENNSYLVANIA 15222/AREA 412/434-2585 ZEB G. BELL, JR,, Sc.D . Manager
Environmental Health and Toxicology Chemicals Group
March 28, 1980
Mr. R. Hines Cleary, Gottlieb, Steen & Hamilton 1250 Connecticut Avenue, N.W. Washington, DC 20036 Dear Mr. Hinds: In accordance with our telephone conversation of Wednesday, March 26, 1980, please find enclosed a copy of the transmittal letter from CMA to Mr. F. Kover at EPA pertaining to the vinyl chloride pathology report. I appreciate your counsel and look forward to discussing this project further if you have any concerns or advise.
Sincerely,
/ta Enclosure
SL 095297
BY MESSENGER
CHEMICAL MANUFACTURERS ASSOCIATION
March 19, 1930
Mr. Frank D. Kover - TS 792 Chief Chemical Hazards Identification
Branch Assessment Division Environmental Protection Agency 401 M Street, S.W. 611 East Tower Washington, D.C. 20460
Dear Mr. Kover:
On January 14, 1977, Mr. Albert Clark forwarded to Mr. Robert McGaughy of EPA, on behalf of the Manufacturing Chemists Association (now the Chemical Manufacturers Asso ciation) , a copy of the protocol and the 23-month status summary for the Association-sponsored research on vinyl chloride at Industrial Bio-Test Laboratories (IBT). Mr. Clark stated in that letter that the final report was expected to be submitted soon, and when available, would be forwarded to the Agency.
As you know, all testing undertaken at IBT has come under a cloud. In particular, serious flaws were discovered in the vinyl chloride study, and no final report of the IBT study was ever issued. The Association undertook to deter mine whether the vinyl chloride study could be validated through an audit of the pathology by Experimental Pathology Laboratories (conducted by Dr. William Busey). Dr. Busey subsequently submitted a report of his audit to the Associa tion on January 9, 1979. It was reviewed by an Association task force and, because it was part of a larger audit (including a review of compliance of IBT with good laboratory practices), was not further distributed at that time. Unfor tunately, because of the interim change in the management of the Association and the extraordinary increase in the scien tific work of the Association caused by the Toxic Substances Control Act and related environmental legislation, we failed to send it to the Agency as a follow-up to Mr. Clark's letter of January 14, 1977.
northerly Manufacturing Chemists Association--Serving the Chemicai Industry SincB 1872. 1825 Connecticut Avenue, NW Washington, DC 20009 Telephone 202/328-4200 Tel
SL 095298
1
Mr. Kover March 19, 1980 Page Two
Recently, the Association has established a task force to oversee and coordinate all scientific testing projects. In the course of reviewing existing projects, this group discovered that we had not made Dr. Busey's audit report on the vinyl chloride study available to the Agency. Accordingly, I am enclosing a copy of the audit report as a follow-up to Mr. Clark's letter of January 14, 1977.
As shown in the interim report sent to the Agency in January, 1977, three suspect brain tumors were noted in male rats at the high dose level. These brain tumors, plus one at the lower dose level, were confirmed by patho logy subsequently conducted by I3T and then by Dr. Busey. Unfortunately, not all of the brain specimens were retained by I3T and not all retained specimens were examined. The Association has therefore concluded to determine whether additional information can be obtained from whatever brain specimens remain at I3T from this highly-flawed study by conducting histopathological examination of all remaining brain tissues. We have not identified any other findings that would appear to warrant further attempts to salvage other information from this study.
We apologize for failing to follow-up on Mr. Clark's earlier letter, and wish to assure you that we will, in the future, keep you apprised of any additional relevant infor mation as it becomes available to us.
While CMA does not itself have a Section 8(e) reporting obligation, and while it appears that this information would not be reportable under Section 8(e) in any event, pursuant to our earlier commitment we are submitting it to the Agency.
Sincerely yours,
Easmukh C. Shah, Ph.D. Director, Special Projects
cc: (with enclosure) Mr. Robert McGaughy . Office of Research & Development Environmental Protection Agency
SL 095299